BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6196502)

  • 1. Langerhans cells and their precursors with S100 protein in mycosis fungoides.
    Igisu K; Watanabe S; Shimosato Y; Kukita A
    Jpn J Clin Oncol; 1983 Dec; 13(4):693-702. PubMed ID: 6196502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal Langerhans cells in mycosis fungoides and Sézary syndrome.
    Matejka M; Konrad K
    Wien Klin Wochenschr; 1983 Dec; 95(23):847-52. PubMed ID: 6670281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical studies using monoclonal antibodies on lymph nodes from patients with mycosis fungoides and Sézary's syndrome.
    Willemze R; Scheffer E; Meijer CJ
    Am J Pathol; 1985 Jul; 120(1):46-54. PubMed ID: 3893151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case of mycosis fungoides with S-100 protein-positive histiocytes].
    Hattori A; Nakajima T; Ishikawa H
    Nihon Hifuka Gakkai Zasshi; 1983 Jul; 93(8):833-9. PubMed ID: 6228682
    [No Abstract]   [Full Text] [Related]  

  • 5. Implication of the ras and myc oncoproteins in the pathogenesis of mycosis fungoides.
    Tosca A; Linardopoulos S; Malliri A; Hatziolou E; Nicolaidou A; Spandidos DA
    Anticancer Res; 1991; 11(4):1433-8. PubMed ID: 1746900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sézary cells in ascitic fluid.
    Vernon SE; Rosenthal DL
    Acta Cytol; 1979; 23(5):408-11. PubMed ID: 316632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mycosis fungoides and Sézary syndrome. A retrospective study of 60 patients with correlation between histologic classification and survival time].
    Hödl S
    Z Hautkr; 1986 Jul; 61(14):993-1013. PubMed ID: 3751216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].
    Vinogradova IuE; Giliazitdinova EA; Zamulaeva IA; Zybunova EE; Kaplanskaia IB; Kravchenko SK; Kremenetskaia AM; Lutsenko IN; Samoĭlova RS; Selivanova EN; Sidorova IuV; Shklovskiĭ-Kord NE
    Ter Arkh; 2005; 77(10):61-5. PubMed ID: 16320688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric study of lymphoid cells in mycosis fungoides and its simulators.
    Sinha AK; Singh MK; Dinda AK; Ramam M
    Indian J Pathol Microbiol; 2003 Jan; 46(1):28-33. PubMed ID: 15027714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
    Nguyen GH; Olson LC; Magro CM
    Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ultrastructure of mycosis fungoides, of Sezary's syndrome, and of Woringer-Kolopp's disease (pagetoid reticulosis).
    Braune-Falco O; Schmoeckel C; Wolff HH
    Bull Cancer; 1977; 64(2):191-208. PubMed ID: 143973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymph node localization of epidermotropic T malignant lymphomas (mycosis fungoides and Sézary's syndrome)].
    Wechsler J; Diebold J; Gérard-Marchant R
    Bull Cancer; 1984; 71(2):89-99. PubMed ID: 6610451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of histiocytes in primary lung cancer stained with anti-S100 protein, lysozyme and OKT 6 antibodies.
    Furukawa T; Watanabe S; Sato Y; Kodama T; Nakajima T; Shimosato Y
    Jpn J Clin Oncol; 1984 Dec; 14(4):647-57. PubMed ID: 6084077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 13-cis-retinoic acid effective in mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Group.
    Thomsen K; Molin L; Volden G; Lange Wantzin G; Hellbe L
    Acta Derm Venereol; 1984; 64(6):563-6. PubMed ID: 6084938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
    Kim YH; Bishop K; Varghese A; Hoppe RT
    Arch Dermatol; 1995 Sep; 131(9):1003-8. PubMed ID: 7661601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-zone histiocytes with S100 protein. Development and distribution in human fetuses.
    Watanabe S; Nakajima T; Shimosato Y; Shimamura K; Sakuma H
    Acta Pathol Jpn; 1983 Jan; 33(1):15-22. PubMed ID: 6837309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cells in the epidermotropic lymphomas (mycosis fungoides and Sézary syndrome. Study using monoclonal antibodies].
    Thivolet J; Schmitt D; Souteyrand P; Brochier J
    Nouv Presse Med; 1982 Oct; 11(41):3033-8. PubMed ID: 6755391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photochemotherapy for mycosis fungoides: a clinical and histological study.
    Lowe NJ; Cripps DJ; Dufton PA; Vickers CF
    Arch Dermatol; 1979 Jan; 115(1):50-3. PubMed ID: 760657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.